North America Drug Device Combination Products Market Size & Outlook

The drug device combination products market in North America is expected to reach a projected revenue of US$ 98,759.2 million by 2030. A compound annual growth rate of 8.1% is expected of North America drug device combination products market from 2024 to 2030.
Revenue, 2023 (US$M)
$57,204.6
Forecast, 2030 (US$M)
$98,759.2
CAGR, 2024 - 2030
8.1%
Report Coverage
North America

North America drug device combination products market, 2018-2030 (US$M)

North
Unlock Premium

Related Markets

North America drug device combination products market highlights

  • The North America drug device combination products market generated a revenue of USD 57,204.6 million in 2023.
  • The market is expected to grow at a CAGR of 8.1% from 2024 to 2030.
  • In terms of segment, transdermal patches was the largest revenue generating product in 2023.
  • Drug Eluting Stents is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.


North America data book summary

Market revenue in 2023USD 57,204.6 million
Market revenue in 2030USD 98,759.2 million
Growth rate8.1% (CAGR from 2023 to 2030)
Largest segmentTransdermal patches
Fastest growing segmentDrug Eluting Stents
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhotodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters
Key market players worldwideAbbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates


Other key industry trends

  • In terms of revenue, North America region accounted for 41.3% of the global drug device combination products market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 66,066.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Drug Device Combination Products Market Scope

Drug device combination products market segmentation & scope
Photodynamic Therapy Devices
Transdermal Patches
Wound Care Products
Others
Volumetric
Disposables
Syringes
Ambulatory
Implantable
Insulin
Bone Graft Implants
Antibiotic Bone Cement
Coronary Stents
Peripheral Vascular Stents
Dry Powder
Nebulizers
Metered Dose
Urological
Cardiovascular
Others

Drug Device Combination Products Market Companies

Name Profile # Employees HQ Website

North America drug device combination products market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.


Transdermal patches was the largest segment with a revenue share of 23.06% in 2023. Horizon Databook has segmented the North America drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.


In 2023, North America dominated the global drug device combination products market. The dominance can be attributed to the well-established healthcare sector, commitment to innovation, advanced infrastructure, a strong emphasis on Research & Development (R&D), and the high prevalence of chronic conditions, such as cardiovascular diseases.

As per the CDC, every year about six in 10 American adults suffer from at least one chronic condition that requires specialized care and attention. Moreover, favorable government regulations and reimbursement policies contribute to market dominance. Regulatory bodies such as the FDA ensure rigorous quality standards, assuring healthcare professionals and patients of the safety & effectiveness of various healthcare products, including drug-device combination products.

Reasons to subscribe to North America drug device combination products market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America drug device combination products market databook

  • Our clientele includes a mix of drug device combination products market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America drug device combination products market , including forecasts for subscribers. This continent databook contains high-level insights into North America drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America drug device combination products market size, by country, 2018-2030 (US$M)

North America Drug Device Combination Products Market Outlook Share, 2023 & 2030 (US$M)

North America drug device combination products market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more